Is Unity Software a Buy Now?
Unity Software (NYSE:U) is the company behind the popular Unity…
Sell
15
UNH Quote, Financials, Valuation and Earnings
Last price:
$291.89
Seasonality move
:
3.2%
Day range:
$269.14 - $294.49
52-week range:
$248.88 - $630.73
Dividend yield:
2.88%
P/E ratio:
12.22x
P/S ratio:
0.66x
P/B ratio:
2.79x
Volume:
70M
Avg. volume:
17.9M
1-year change:
-44%
Market cap:
$264.8B
Revenue:
$400.3B
EPS (TTM):
$23.88
Analysts' Opinion
-
Consensus RatingUnitedHealth Group has received a consensus rating of Buy. The company's average rating is a Buy based on 16 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $431.37, UnitedHealth Group has an estimated upside of 47.78% from its current price of $291.91.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $350.00 representing -19.9% downside risk from its current price of $291.91.
Fair Value
-
According to the consensus of 20 analysts, UnitedHealth Group has 47.78% upside to fair value with a price target of $431.37 per share.
UNH vs. S&P 500
-
Over the past 5 trading days, UnitedHealth Group has underperformed the S&P 500 by -27.15% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
UnitedHealth Group does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
UnitedHealth Group has grown year-over-year revenues for 142 quarters straight. In the most recent quarter UnitedHealth Group reported revenues of $109.6B.
Earnings Growth
-
UnitedHealth Group has grown year-over-year earnings for 2 quarters straight. In the most recent quarter UnitedHealth Group reported earnings per share of $6.85.
Enterprise value:
321.9B
EV / Invested capital:
1.73x
Price / LTM sales:
0.66x
EV / EBIT:
9.99x
EV / Revenue:
0.79x
PEG ratio (5yr expected):
0.27x
EV / Free cash flow:
12.95x
Price / Operating cash flow:
10.87x
Enterprise value / EBITDA:
8.84x
Gross Profit (TTM):
$90.2B
Return On Assets:
7.48%
Net Income Margin (TTM):
5.39%
Return On Equity:
21.74%
Return On Invested Capital:
12.37%
Operating Margin:
8.32%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $335.9B | $379.5B | $410.1B | $99.8B | $109.6B | |
| Gross Profit | $83.2B | $91.3B | $90.2B | $23B | $23.8B | |
| Operating Income | $29.6B | $32.2B | $33.5B | $7.9B | $9.1B | |
| EBITDA | $33.2B | $29.1B | $36.4B | $1.8B | $10.2B | |
| Diluted EPS | $21.87 | $16.36 | $23.88 | -$1.53 | $6.85 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $59.5B | $69B | $93.9B | $88.9B | $96.3B | |
| Total Assets | $205.2B | $221.2B | $283.7B | $284.2B | $309.8B | |
| Current Liabilities | $80.6B | $88.2B | $116.5B | $104.4B | $113.5B | |
| Total Liabilities | $134.6B | $143.6B | $193.1B | $187.3B | $204.6B | |
| Total Equity | $70.6B | $77.6B | $90.6B | $96.9B | $105.2B | |
| Total Debt | $46.3B | $47.5B | $70.6B | $73.6B | $81.3B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $37.2B | $13.9B | $28.5B | $1.1B | $5.5B | |
| Cash From Investing | -$35.8B | -$10.9B | -$14.3B | -$6.3B | -$74M | |
| Cash From Financing | $15.1B | -$16.5B | -$11.6B | $8.2B | $99M | |
| Free Cash Flow | $34.2B | $10.5B | $24.9B | $401M | $4.6B | |
UNH
Sector
Market Cap
$264.8B
$33.9M
Price % of 52-Week High
46.28%
42.73%
Dividend Yield
2.88%
0%
Shareholder Yield
2.33%
-0.67%
1-Year Price Total Return
-44%
-42.23%
Beta (5-Year)
0.561
0.657
Dividend yield:
2.88%
Annualized payout:
$8.18
Payout ratio:
34.91%
Growth streak:
15 years
Technicals
8-day SMA
Sell
Level
$340.21
200-day SMA
Sell
Level
$535.58
Bollinger Bands (100)
Sell
Level
427.81 - 554.67
Chaikin Money Flow
Buy
Level
374.4M
20-day SMA
Sell
Level
$384.28
Relative Strength Index (RSI14)
Sell
Level
19.76
ADX Line
Sell
Level
48.42
Williams %R
Neutral
Level
-75.1085
50-day SMA
Sell
Level
$468.27
MACD (12, 26)
Sell
Level
-50.42
25-day Aroon Oscillator
Sell
Level
-92
On Balance Volume
Neutral
Level
322M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (3.4048)
Sell
CA Score
(Annual)
Level (-0.3766)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (7)
Buy
Ohlson Score
Level (-0.5939)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (9)
Revenue Forecast
Earnings per Share Forecast
Company Profile
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
Stock Forecast FAQ
In the current month, UNH has received 16 Buy ratings 4 Hold ratings, and 0 Sell ratings. The UNH average analyst price target in the past 3 months is $431.37.
-
Where Will UnitedHealth Group Stock Be In 1 Year?
According to analysts, the consensus estimate is that UnitedHealth Group share price will rise to $431.37 per share over the next 12 months.
-
What Do Analysts Say About UnitedHealth Group?
Analysts are divided on their view about UnitedHealth Group share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that UnitedHealth Group is a Sell and believe this share price will drop from its current level to $350.00.
-
What Is UnitedHealth Group's Price Target?
The price target for UnitedHealth Group over the next 1-year time period is forecast to be $431.37 according to 20 Wall Street analysts, 16 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.
-
Is UNH A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for UnitedHealth Group is a Buy. 16 of 20 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of UNH?
You can purchase shares of UnitedHealth Group via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase UnitedHealth Group shares.
-
What Is The UnitedHealth Group Share Price Today?
UnitedHealth Group was last trading at $291.89 per share. This represents the most recent stock quote for UnitedHealth Group. Yesterday, UnitedHealth Group closed at $291.91 per share.
-
How To Buy UnitedHealth Group Stock Online?
In order to purchase UnitedHealth Group stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Uber Stock 5X?
Uber (NYSE:UBER) has generated extremely strong returns for its investors…
How High Will Bloom Energy Stock Go?
Bloom Energy (NYSE:BE) has seen its shares surge by more…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 38x
Buy
71
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 46x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Alerts
Buy
81
SMLR alert for May 17
Semler Scientific [SMLR] is up 28.56% over the past day.
Sell
25
GLOB alert for May 17
Globant SA [GLOB] is down 23.54% over the past day.
Buy
94
HIMS alert for May 17
Hims & Hers Health [HIMS] is up 10.38% over the past day.
